Thyroid Tumors (Black Box Warning) Mounjaro carries the FDAs most serious warning regarding thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on animal studies
Therefore, these equations cannot be used in patients with exogenous insulin use ( Despite important knowledge gaps in our understanding of IR in T1D, targeting IR in overweight/obese patients with T1D may decrease the risk of diabetes complications, contribute to weight loss, and improve glycemic control
underarousal in frontal and midline cortical regions is found in up to 90% of cases, and frontal hyperarousal is especially noted in individuals who have not responded to stimulants
Global regulatory frameworksespecially the ICH S1 series guidelinesrequire structured carcinogenicity assessment: ICH S1A/S1B/S1C define when lifetime rodent studies are required Emphasis on hazard identification rather than direct human prediction Adoption of Weight-of-Evidence (WoE) approaches in ICH S1B(R1) The updated S1B(R1) guideline specifically encourages: Integration of mechanistic, exposure, and translational data Reduced reliance on 2-year rodent bioassays when justified Greater emphasis on human relevance and multi-factor evidence This shift reflects a broader regulatory evolution toward mechanism-based safety assessment rather than purely animal-driven hazard signals